Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.07 – $6.66
0% from low
Exchange
OTC Link
CS
Borrow rate
15.26%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.1M | $9.9M | $14.5M | $79.0M | $122.6M | $44.4M | $6.8M | $4.3M |
| Cost of revenue | $8.3M | $7.3M | $9.9M | $46.2M | $52.0M | $28.1M | $6.9M | $3.0M |
| Gross profit | $4.8M | $2.6M | $4.6M | $32.8M | $70.7M | $16.2M | −$150.0K | $1.4M |
| Gross margin | 36.4% | 26.5% | 31.7% | 41.5% | 57.6% | 36.6% | -2.2% | 31.9% |
| R&D | $398.0K | $332.0K | $633.0K | $520.0K | $652.0K | $1.4M | $594.0K | $107.0K |
| Operating income | −$1.6M | −$3.2M | −$4.0M | $9.8M | $23.6M | −$21.6M | −$38.6M | −$18.0M |
| EBITDA | −$1.3M | −$2.7M | −$1.5M | $11.4M | $28.7M | −$14.8M | −$32.3M | −$11.4M |
| Net income | −$1.7M | −$3.1M | −$2.1M | $6.3M | $18.5M | −$16.8M | −$53.4M | −$14.7M |
| Net margin | -13.3% | -31.9% | -14.6% | 7.9% | 15.1% | -37.8% | -788.2% | -339.3% |
| EPS (diluted) | -1.50 | -2.60 | -2.00 | 4.00 | 10.20 | -9.80 | -26.10 | -1.74 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $42M | $10.40 | $10.40–$10.40 | 1 |
Forward consensus · source: Financial Modeling Prep
PROPHASE LABS INC
No one on the platform currently holds PRPH.
No tracked institution reports a position in PRPH as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-12-22 | 1-for-10reverse |
No one on the platform has traded PRPH yet.
| $18M |
| — |
| BFRIBiofrontera Inc. | $1.02 | +5.05% | $13M | — |
| CODXCo-Diagnostics, Inc. | $2.98 | -2.61% | $3M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 0.0× sales vs its 2.6× historical median P/S.
Fair value ≈ $9.66 · price $0.09 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$ILLR Remember $PRPH I’m going to give this the same treatment if it closes under $1 😈
View on StockTwits ↗$PRPH Waiting for My Royale CROWN Collection Suzie $WalloW$ $$$$
View on StockTwits ↗$PRPH Ted Karkus, How about realizing some value from the B-Smart with an entity interested in Commercializing it? And where's any realized portion of that $50 + Million USD in Crown Medical Collections ?
View on StockTwits ↗$PRPH After a long wait, Ted has conjured up the annual figures—abracadabra. https://www.sec.gov/Archives/edgar/data/868278/000086827826000005/prph-20251231.htm
View on StockTwits ↗$PRPH Jason Karkus (pic left) and Ted Karkus (pic right) ***** What's the Stoooory Teddy?
View on StockTwits ↗$IBO $PRPH $DSS So if history repeats itself as it always has, then there will be a mega pump and dump soon. Look at $PRPH, same actors with the same fairy tales. So for the adventurers who want to make some quick money, buy some IBO junk bit by bit now and sell the junk for more during the pump and dump, because that will be your only chance to dump this junk without loss 🕵️♂️🧑🏫🦮🥷 .https://www.sec.gov/Archives/edgar/data/1834105/000149315226019682/xsl144X01/primary_doc.xml
View on StockTwits ↗$PRPH When did the management decide to refocus their energies on ball sucking?
View on StockTwits ↗$PRPH https://ir.prophaselabs.com/news-events/press-releases/detail/266/prophase-labs-reports-year-end-2025-results-highlights
View on StockTwits ↗$PRPH Ted, please come through... we're counting on you.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.